A Phase Ib/II study of IGF-neutralising antibody xentuzumab with enzalutamide in metastatic castration-resistant prostate cancer

Macaulay, Valentine M.; Lord, Simon; Hussain, Syed; Maroto, Jose Pablo; Jones, Robert Hugh; Climent, Miguel Angel; Cook, Natalie; Lin, Chia-Chi; Wang, Shian-Shiang; Bianchini, Diletta; Bailey, Mark; Schlieker, Laura; Bogenrieder, Thomas; de Bono, Johann

dc.contributor.author	Bogenrieder, Thomas	de_DE
dc.date.accessioned	2024-01-11T11:50:39Z
dc.date.available	2024-01-11T11:50:39Z
dc.date.issued	2023
dc.identifier.issn	0007-0920
dc.identifier.uri	http://hdl.handle.net/10900/149160
dc.language.iso	en	en
dc.publisher	London : Springernature	de_DE
dc.relation.uri	http://dx.doi.org/10.1038/s41416-023-02380-1
dc.subject.ddc	610	de_DE
dc.title	A Phase Ib/II study of IGF-neutralising antibody xentuzumab with enzalutamide in metastatic castration-resistant prostate cancer	de_DE
dc.type	Article	de_DE
utue.quellen.id	20230928000000_00291
utue.publikation.seiten	965-973	de_DE
utue.personen.roh	Macaulay, Valentine M.
utue.personen.roh	Lord, Simon
utue.personen.roh	Hussain, Syed
utue.personen.roh	Maroto, Jose Pablo
utue.personen.roh	Jones, Robert Hugh
utue.personen.roh	Climent, Miguel Angel
utue.personen.roh	Cook, Natalie
utue.personen.roh	Lin, Chia-Chi
utue.personen.roh	Wang, Shian-Shiang
utue.personen.roh	Bianchini, Diletta
utue.personen.roh	Bailey, Mark
utue.personen.roh	Schlieker, Laura
utue.personen.roh	Bogenrieder, Thomas
utue.personen.roh	de Bono, Johann
dcterms.isPartOf.ZSTitelID	British Journal of Cancer	de_DE
dcterms.isPartOf.ZS-Issue	6	de_DE
dcterms.isPartOf.ZS-Volume	129	de_DE
utue.fakultaet	04 Medizinische Fakultät